Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis

Citation
M. Steinhoff et al., Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis, REGUL PEPT, 80(1-2), 1999, pp. 49-55
Citations number
23
Categorie Soggetti
Physiology
Journal title
REGULATORY PEPTIDES
ISSN journal
01670115 → ACNP
Volume
80
Issue
1-2
Year of publication
1999
Pages
49 - 55
Database
ISI
SICI code
0167-0115(19990317)80:1-2<49:IOPACA>2.0.ZU;2-T
Abstract
Morphological and biochemical evidence is presented for the presence of pit uitary adenylate cyclase activating peptide (PACAP) and the high-affinity P ACAP-1 receptor subtype in human skin. Immunohistochemical analysis reveale d PACAP-immunoreactivity (IR) to be present predominantly in dermal nerve f ibers close to the dermal-epidermal border, hair follicles, blood vessels a nd sweat glands. Radioimmunoassay, chromatographic analysis and Western blo tting revealed this PACAP-IR to be PACAP-38 whereas the second molecular fo rm, PACAP-27, is absent. In tissue of psoriasis patients significantly more PACAP-38 protein was detected as compared to normal skin. Using RT-PCR, th e expression of a high-affinity PACAP-1 receptor in human skin was observed . These results indicate a possible role for PACAP-38 in inflammatory proce sses of psoriasis. (C) 1999 Elsevier Science B.V. All rights reserved.